Company Search:
Advanced Search
Sponsored Links
Durect Corporation Company Snapshot
Durect Corporation operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Durect with three other companies in this sector in the United States: Strongbridge Biopharma plc (2018 sales of $18.03 million of which 93% was Keveyis), Tetraphase Pharmaceuticals Inc ($18.90 million of which 100% was Biopharmaceuticals), and Cerecor Inc ($18.33 million ).

Sales Analysis. Durect reported sales of $18.56 million for the year ending December of 2018. This represents a sharp decrease of 62.2% versus 2017, when the company's sales were $49.17 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Durect Corporation
  Stock Performance Chart for Durect Corporation
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 1.90
(Figures in U.S. Dollars)
1 Week 3.3%   13 Weeks 11.8%  
4 Weeks 31.9%   52 Weeks 108.8%  
Durect Corporation Key Data:
  Ticker: DRRX Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 18,564,000
(Year Ending Jan 2019).
Employees: 88
  Currency: U.S. Dollars Market Cap: 365,488,140
  Fiscal Yr Ends: December Shares Outstanding: 192,362,179
  Share Type: Common Closely Held Shares: 6,426,659
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.